quinoxalines has been researched along with 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheong, YH; Kaang, BK; Kim, MK; Son, MH | 1 |
1 other study(ies) available for quinoxalines and 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine
Article | Year |
---|---|
Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently.
Topics: Animals; Calcium; CHO Cells; Cricetinae; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Peptides; Pyrimidines; Quinoxalines; Receptors, Glucagon; Sulfones; Venoms | 2012 |